new video loaded: W.H.O. Approves China’s Sinopharm Covid-19 Vaccine
W.H.O. Approves China’s Sinopharm Covid-19 Vaccine
The World Health Organization’s authorization of the vaccine for emergency use on Friday allows it to be included in Covax, W.H.O’s global initiative to increase vaccine access in low- and middle-income countries.
Solving the vaccine crisis requires that we pull out all the stops. W.H.O. is continuing to explore every avenue for increasing access to vaccines globally. This afternoon, W.H.O. gave emergency-use listing to Sinopharm, Beijing’s Covid-19 vaccine, making it the sixth vaccine to receive W.H.O. validation for safety, efficacy and quality. This expands the list of vaccines that Covax can buy, and gives countries confidence to expedite their own regulatory approval and to import and administer a vaccine. The strategic advisory group of experts on immunization, or SAGE, has also reviewed the available data and recommends the vaccine for adults 18 years and older, with a two-dose schedule. Vaccines remain a vital tool. But right now, the volume and distribution of vaccines is insufficient to end the pandemic without the sustained and tailored application of public health measures that we know work.
Recent episodes in Coronavirus Pandemic: Latest Updates
World News || Latest News || U.S. News